DWM
ABBV icon

Dopkins Wealth Management’s AbbVie ABBV Stock Holding History

Dopkins Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,142
Closed -$248K – 91
2026
Q1 		$248K Buy
+1,142
New +$253K 0.1% 81
2025
Q2 		– Sell
-1,150
Closed -$241K – 83
2025
Q1 		$241K Hold
1,150
– – 0.12% 70
2024
Q4 		$204K Buy
+1,150
New +$211K 0.1% 82

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dopkins Wealth Management's ABBV Position: Q2 2026 in Review

Dopkins Wealth Management sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 1,142 shares — an estimated $248K sold.

Dopkins Wealth Management first reported a position in ABBV in Q4 2024 and held it in 3 quarters. The position peaked at $248K in Q1 2026. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Dopkins Wealth Management reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
  • Dopkins Wealth Management sold 1,142 AbbVie shares in Q2 2026, an estimated $248K.
  • Dopkins Wealth Management first reported a position in AbbVie in Q4 2024 and held it in 3 quarters.
  • Dopkins Wealth Management's AbbVie position peaked at $248K in Q1 2026.
  • 4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Dopkins Wealth Management's 13F filing for Q2 2026, filed 14 Jul 2026.